Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics-Reference-Cited by-同舟云学术

Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics

Published:2017-01-01 Issue:1 Volume:24 Page:1216-1229
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Wu Haibin¹²,Wang Meng³,Dai Bo⁴⁵,Zhang Yanmin¹,Yang Ying¹,Li Qiao⁶,Duan Mingyue¹,Zhang Xi¹,Wang Xiaomei¹,Li Anmao¹,Zhang Liyu¹²

Affiliation:

1. Shaanxi Institute of Pediatric Diseases, Xi’an Children’s Hospital, Xi’an, Shaanxi, People’s Republic of China;

2. Key laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, People’s Republic of China;

3. Department of Orthopedics, The No.11 Hospital of PLA, YiNing, XinJiang, People’s Republic of China;

4. Shaanxi Center for Stem Cell Application Engineering Research, Xi’an, Shaanxi, People’s Republic of China;

5. Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi’an Medical University, Xi’an, Shaanxi, People’s Republic of China;

6. Clinical Laboratory, Xi’an Children’s Hospital, Xi’an, Shaanxi, People’s Republic of China

Funder

National Natural Science Foundation of China

Xi’an Science and Technology program

Xi 'an Science Technology proram

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/10717544.2017.1367976

Reference60 articles.